STSS Stock Overview
Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Sharps Technology, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.31 |
52 Week High | US$1.58 |
52 Week Low | US$0.27 |
Beta | 1.03 |
1 Month Change | 2.14% |
3 Month Change | -2.54% |
1 Year Change | -74.82% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -85.08% |
Recent News & Updates
Recent updates
Shareholder Returns
STSS | US Medical Equipment | US Market | |
---|---|---|---|
7D | -7.1% | -4.1% | -3.7% |
1Y | -74.8% | -2.2% | 20.5% |
Return vs Industry: STSS underperformed the US Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: STSS underperformed the US Market which returned 20.2% over the past year.
Price Volatility
STSS volatility | |
---|---|
STSS Average Weekly Movement | 13.5% |
Medical Equipment Industry Average Movement | 7.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: STSS's share price has been volatile over the past 3 months.
Volatility Over Time: STSS's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | 57 | Robert Hayes | sharpstechnology.com |
Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc. Fundamentals Summary
STSS fundamental statistics | |
---|---|
Market cap | US$4.89m |
Earnings (TTM) | -US$9.84m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.5x
P/E RatioIs STSS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
STSS income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$9.84m |
Earnings | -US$9.84m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.63 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did STSS perform over the long term?
See historical performance and comparison